- Home
- INBX vs CII Comparison
INBX vs CII Comparison
Compare INBX & CII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | INBX | CII |
|---|---|---|
| Founded | 2010 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 963.2M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | INBX | CII |
|---|---|---|
| Price | $76.49 | $22.54 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 201.6K | 78.8K |
| Earning Date | 03-16-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 6.17% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,400,000.00 | N/A |
| Revenue This Year | $563.00 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $10.81 | $16.76 |
| 52 Week High | $94.57 | $19.81 |
Technical Indicators
Market Signals| Indicator | INBX | CII |
|---|---|---|
| Relative Strength Index (RSI) | 56.01 | 36.18 |
| Support Level | $77.24 | $22.39 |
| Resistance Level | $88.72 | $23.25 |
| Average True Range (ATR) | 4.93 | 0.32 |
| MACD | 0.54 | -0.04 |
| Stochastic Oscillator | 68.86 | 8.25 |
Price Performance
Historical ComparisonAbout INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
About CII Blackrock Capital and Income Fund Inc.
Blackrock Enhanced Cap&Inc Fund, Inc is a closed-end management investment company. Its objective is to provide total return through a combination of current income and capital appreciation. The trust seeks to achieve its investment objective by investing a majority of its total assets in a portfolio of equity securities of U.S. and foreign issuers.